Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.
暂无分享，去创建一个
G. Giaccone | S. Steinberg | M. Raffeld | D. Gandara | R. Salgia | E. Vokes | S. Khozin | L. Doyle | U. Guha | J. Trepel | L. Xi | Y. Tomita | Anish Thomas | Sunmin Lee | A. Rajan | C. Carter | K. Reckamp | B. Gitlitz | S. Koehler | Éva Szabó | Christina E. Brzezniak | M-J. Lee | Corrine Keen